Literature DB >> 28107619

Peptide-Based Stealth Nanoparticles for Targeted and pH-Triggered Delivery.

Alessandro Ranalli1, Melissa Santi1, Luigi Capriotti2, Valerio Voliani2, David Porciani1,2, Fabio Beltram1, Giovanni Signore1,2.   

Abstract

Stealth agents are extensively investigated as a means by which to prolong nanostructure residence time in the bloodstream by avoiding uptake by the reticuloendothelial system. Unfortunately, commonly used agents such as poly(ethylene glycol) can adversely impact targeting efficiency and promote immune reaction by the host organism. Therefore, there is an increasing interest in developing biocompatible, non-PEGylated organic nanostructures able to perform targeted delivery to increase the efficacy of liposomal technology. Here, a lipopeptide is presented that can be mixed with lipids commonly used in liposomal formulations in percentages ranging from 20% to 60% w/w. The resulting vesicles are thermally and chemically stable. The peptide coating limits serum-protein adsorption even upon prolonged incubation in pure serum in physiological conditions, outperforming PEGylated liposomes. This architecture can be easily modified to allow straightforward derivatization by standard bio-orthogonal conjugation. Upon derivatization with an anti-transferrin receptor aptamer, these vesicles show highly selective cellular internalization with minimal nonspecific uptake and pH-triggered doxorubicin release.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28107619     DOI: 10.1021/acs.bioconjchem.6b00701

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  6 in total

Review 1.  Bioinspired Shielding Strategies for Nanoparticle Drug Delivery Applications.

Authors:  Neetu M Gulati; Phoebe L Stewart; Nicole F Steinmetz
Journal:  Mol Pharm       Date:  2018-05-15       Impact factor: 4.939

Review 2.  Targeting Inflammation With Nanosized Drug Delivery Platforms in Cardiovascular Diseases: Immune Cell Modulation in Atherosclerosis.

Authors:  Antonio Cervadoro; Roberto Palomba; Giuseppe Vergaro; Roberta Cecchi; Luca Menichetti; Paolo Decuzzi; Michele Emdin; Stefano Luin
Journal:  Front Bioeng Biotechnol       Date:  2018-11-27

Review 3.  The Therapeutic Potential of Nanoparticles to Reduce Inflammation in Atherosclerosis.

Authors:  Armita Mahdavi Gorabi; Nasim Kiaie; Željko Reiner; Federico Carbone; Fabrizio Montecucco; Amirhossein Sahebkar
Journal:  Biomolecules       Date:  2019-08-26

4.  Novel mitochondrial targeting charge-reversal polysaccharide hybrid shell/core nanoparticles for prolonged systemic circulation and antitumor drug delivery.

Authors:  Lei Fang; Wei Zhang; Zhen Wang; Xinxin Fan; Ziting Cheng; Xiaoya Hou; Daquan Chen
Journal:  Drug Deliv       Date:  2019-12       Impact factor: 6.419

5.  Targeted Dendrimer-Coated Magnetic Nanoparticles for Selective Delivery of Therapeutics in Living Cells.

Authors:  Paola Parlanti; Adriano Boni; Giovanni Signore; Melissa Santi
Journal:  Molecules       Date:  2020-05-10       Impact factor: 4.411

6.  Novel Use of Hypoxia-Inducible Polymerizable Protein to Augment Chemotherapy for Pancreatic Cancer.

Authors:  Andrew Gdowski; Hamed Hayatshahi; Rafal Fudala; Rohan Joshi; Jin Liu; Jamboor K Vishwanatha; Rohan Jeyarajah; Paul Guzik; Amalendu P Ranjan
Journal:  Pharmaceutics       Date:  2022-01-05       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.